REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

RADAYDRUG Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: RADAYDRUG Szolgaltato, Tanacsado es Innovacios Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

radaydrug is a company specializing in designing, constructing, and operating safety systems for medicines, medical devices, and cosmetics in the European Union. They offer Product Leaflets (PLs) and surveillance systems for their clients.

Headquarters
Rozsavolgy utca 151.
Debrecen; Hajdu-Bihar; Postal Code: 4225

Contact Details: Purchase the RADAYDRUG Kft. report to view the information.

Website: http://www.radaydrug.com

Basic Information
Total Employees:
Purchase the RADAYDRUG Kft. report to view the information.
Outstanding Shares:
Purchase the RADAYDRUG Kft. report to view the information.
Incorporation Date:
October 12, 2001
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after RADAYDRUG Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-21.22%▼
Total operating revenue
-21.53%▼
Operating profit (EBIT)
-54.97%▼
EBITDA
-53%▼
Net Profit (Loss) for the Period
-65.18%▼
Total assets
-8.13%▼
Total equity
-43.34%▼
Operating Profit Margin (ROS)
-22.9%▼
Net Profit Margin
-29.69%▼
Return on Equity (ROE)
-25.89%▼
Quick Ratio
-1.34%▼
Cash Ratio
-1.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo